Updated:
Global Cardiovascular Innovation Center
The Global Cardiovascular Innovation Center is a consortium led by the Cleveland Clinic, established through a State of Ohio Third Frontier Project grant.
Overview
The Global Cardiovascular Innovation Center is a consortium led by the Cleveland Clinic, established through a State of Ohio Third Frontier Project grant. It comprises Case Western Reserve University, The Ohio State University, The University of Cincinnati, The University of Toledo, and University Hospitals of Cleveland. GCIC has made 5 investments, including a 2017 investment in Sense Neuro Diagnostics, and has 2 portfolio exits, including Vectorious Medical Technologies in 2023.
General information
Location
Region
North America
Country
United States
City
Ann Arbor
Corporate office
Ann Arbor, MI, United States
Additional offices
St. Louis, MO, United States · Cleveland, OH, United States · Marlborough, MA, United States · Portland, OR, United States
Sector focus
Frequently asked questions
What does the Global Cardiovascular Innovation Center do?
GCVCC is a nonprofit consortium that accelerates cardiovascular device and therapy development. It provides infrastructure for prototyping, preclinical testing, clinical trials, and regulatory navigation, working with academic and industry partners (public record).
How is GCVCC structured as an organization?
GCVCC operates as a nonprofit entity with a distributed consortium model. It has offices or partnerships in Ann Arbor, St. Louis, Cleveland, Marlborough, and Portland, but does not disclose a central executive team or ownership structure (public record).
What types of organizations partner with GCVCC?
GCVCC partners with academic medical centers, hospitals, medical device companies, and government entities to facilitate cardiovascular innovation. Specific partner names are not publicly detailed (public record).
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: